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1. ABBREVIATIONS 
 
 
 
 
BLAST - Basic Local Search Alignment Local Tool 
 
BME - β-Mercaptoethanol 
 
CHIP - C-Terminal peptide from Human Hsp90 
 
DNA - Deoxyribonucleic Acid 
 
DOPE Score - Discrete Optimized Protein Energy Score 
 
E1 - Ubiquitin activating enzyme 
 
E2 - Ubiquitin conjugating enzyme 
 
E3 - Ubiquitin Ligase 
 
HSP - Heat Shock Protein 
 
IPTG - Isopropyl β-D-1-thiogalactopyranoside 
 
Lys48 - Lysine 48 linkage of Ubiquitin 
 
Lys63 - Lysine 63 linkage of Ubiquitin 
 
Mms2 - Methyl methanosulfonate2 
 
NCBI - National Center for Biotechnology Information 
 
NEMO - Nuclear Factor-kB Essential Modulator 
 
NMR - Nuclear Magnetic Resonance 
 
O.D - Optical Density 
 
PCNA - Proliferating Cell Nuclear Antigen 
 
PCR - Polymerase Chain Reaction 
 
PMSF - Phenylmethylsulfonyl fluoride 
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Poly-Ub - Poly-Ubiquitin chains 
 
PRR - Post-replicative Repair Pathway 
 
RAD - RADiation Sensitive 
 
RING - Really Interesting New Gene 
 
SAPKs - Stress-Activated Protein Kinases 
 
SSBs - Single Stranded Binding Proteins 
 
TRAF - Tumor Necrosis Factor (TNF) Receptor Associated Factor 
 
Ubs - Ubiquitins 
 
UEV - Ubiquitin-conjugating Enzyme Variant 
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2. ABSTRACT: 
 
Part I 
 
Mms2, a Ubiquitin-conjugating enzyme variant (UEV) protein acts a co-factor for Ubc13 in DNA 
damage repair. This signaling is mediated by assembly of Lys-63 linked poly-ubiquitin chains by 
Ubc13 and Mms2 complex. Uev1A, another UEV in conjugation with Ubc13 forms Lys-63 poly-
ubiquitin chains which lead to activation of NF-kB pathway. Hence, in the presence of different 
cofactors, Ubc13 performs distinct biological functions. Mms2 and Uev1A were found to have a 
sequence similarity of more than 90%. This project aims at generating five mutants of Mms2 by 
changing the residues to that of Uev1A and studying their interaction with Ubc13. 
 
Part II 
 
Uev1a is a UEV protein that associates with Ubc13, an E2 enzyme to form Lys63 linked poly-Ub 
chains. Uev1a possess the core UEV domain but lack the active site cysteine rendering it 
catalytically inactive. The 35 residue long N-terminus is unstructured in the solution structure of 
Uev1a. Ubc13-Uev1a heterodimer interact with E3 ligases to ubiquitinate proteins downstream. 
CHIP and TRAF6 are E3 ligases possessing U box and RING domains respectively which 
interact with the E2 heterodimer for further ubiquitination of target proteins. There is a lack of 
structural data on interaction of N-terminal 35 residues of Uev1a with TRAF6 and CHIP. This 
project aims at understanding the possible interactions of Uev1a N-Terminal residues with the 
available crystal structure of Ubc13-Uev1a-CHIP after modeling the peptide and docking it onto 
the heterotrimer complex. 
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3. INTRODUCTION: 
 
3.1 Ubiquitination: 
 
Post-translational modifications are highly significant for regulation of protein functions. One 
such fundamental post-translational modification is ubiquitination which involves the covalent 
attachment of ubiquitin to target protein. Ubiquitin is an 8 kDa regulatory protein, with 76 amino 
acids terminating in a diglycine sequence (Pickart and Eddins 2004). Ubiquitin harbors seven 
Lysine residues, K6, K11, K27, K29, K33, K48 and K63. 
 
Mono-ubiquitination involves formation of an isopeptide bond between ubiquitin and lysine 
residue of target protein. Extension of ubiquitin chains on target protein occurs via one of the 
seven lysine residues of ubiquitin (Clague and Sylvie 2010). 
 
Ubiquitination involves cascade of three classes of enzymes E1, E2 and E3. E1, Ub-activating 
enzyme forms a thioester bond between cysteine in its active site and C-Terminus of Ub. 
Activated Ub then forms similar thioester-linked complex with Ub- conjugating enzyme (E2). 
Subsequently, Ub is covalently attached to substrate protein by E3, Ub-Ligase (E3). Although 
E2 and E3 are found more than one in organisms, E1 is one. The higher number of E3 in 
comparison to E2 can be explained by the observation that E3 acts as the primary substrate 
recognition factor in the ubiquitination reaction, whereas E2 is thought to be involved in the 
reaction largely through its association with a given E3 (Finley and Vincent 1991). Specificity of 
E2/E3 interaction decides the final biological destination of ubiquitin carried by a particular E2 
(Pickart and Eddins 2004). Schematic representation of ubiquitination reaction is shown in 
Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
Figure1: Schematic representation of the ubiquitination cascade. Ubiquitin is activated by E1, then 
 
transferred to an E2 as it forms a thio-ester bond, and transferred by an E3 to a lysine residue of a 
substrate. 
 
Specificity of Ubiquitination: The E3 binds its substrate and its specific E2 partner at separate sites. 
 
(Adapted from Pickart 2001) 
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Poly-ubiquitination of substrates can be linked through different lysines present in ubiquitin. 
Poly-Ub chains linked through Lys48-G76 isopeptide bonds are the principal signal for 
proteasomal proteolysis. Poly-ubiquitination through Ub Lys48 requires a chain of at least 4 Ubs 
linked to the target protein for proteasomal degradation via 26S proteasome (Thrower et al. 
2000). Lys63 linked Ub chains can regulate kinase activation, DNA damage tolerance, signal 
transduction, and endocytosis (Passmore et al. 2004). 
 
3.2 Ubc13 and its function: 
 
UBCs are a class of structurally related proteins and they catalyze transfer of ubiquitin to 
substrate protein (Hochstrasser & Mark 1996). Ubc13 is an E2 enzyme that has been involved 
in the assembly of Lys-63 linked poly-ubiquitin chains instead of the conventional Lys-48 
assembly. This enzyme in association with various partners, functions in innate immune 
response, DNA-damage repair, control cell cycle progression. For Ubc13 to carry out its 
function, UEV (Ubc Variant) is required as a co-factor (Hoffman et al. 1999) Uev1A which is 
homologous to Mms2 is also a Uev that acts as a cofactor for Ubc13. Ubc13 and Uev1A are 
required for TRAF6-mediated NF-kB activation which is triggered via bacterial 
lipopolysaccharide. Uev1A also mediate TRAF-6 induced NEMO polyubiquitination. Uev 
proteins show sequence identity yet have distinct biological functions. Ubc13, E2 carries out a 
function when associated with Mms2 and a different function when associated with Uev1A. 
Figure 3 shows the two different functions carried out by UBC13 when associated with different 
UEVs (Anderson et al. 2005). Pair wise sequence alignment of Mms2 and Uev1A was 
performed in Clustal Omega using Global Alignment method (Figure 2). 
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Figure2: Amino acid sequence alignment of Uev1A and Mms2. Residues to be mutated are 
indicated by red arrows. (Sequences from Uniprot and Pairwise alignment by Clustal Omega) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure3: A working model of Ubc13–Uev functions in human cells. When co-factor is Mms2 for 
Uev1A, the complex plays a role in DNA damage repair. When co-factor is UEV1A, complex 
confers innate immunity. 
 
 
In yeast, Ubc13-Mms2 complex is recruited to DNA damage site by RING finger protein RAD5, 
via its RING finger domain. RAD5 acts as a bridging factor to bring Ubc13 and Mms2 into 
contact with the RAD6-RAD18 complex. Ubc13 and Mms2 both of which are cytosolic proteins 
are redistributed to nucleus on DNA damage. A model proposed in the assembly of repair 
complexes explains that self-association of RAD18 can promote recruitment of multiple RAD6 
but heteromeric association of RAD5 and RAD18 results in the complex formation with two 
Ubcs: RAD6 and Ubc13-Mms2. This heteromeric complex then function in error-free repair, 
resulting in the formation of Lys-63 linked poly-ubiquitin chains. Homo-dimers of RAD18 could 
recruit RAD6 substrates independently of Ubc13-Mms2 which may lead to mono-ubiquitination 
or Lys-48 linked chains. The figure 4 below explains the heteromeric and homodimeric 
association of RAD5 and RAD18 (Ulrich et al. 2000). 
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Figure 4: Model for alternative repair complexes within the RAD6 pathway of DNA repair. 
 
Homodimerization of RAD18 leads to assemblies comprising RAD6 as the sole UBC, whereas 
heterodimerization with RAD5 recruit UBC13-MMS2 along with RAD6 for assembly of Lys-63 linkage. 
(Adapted from Ulrich et al.2000) 
 
3.3 Interaction between Ubc13 and Mms2: 
 
 
Crystal Structure of complex between hMms2 and hUbc13 was resolved at 1.85 Å resolutions. 
Their interacting interface provides a physical basis for preference of Mms2 for Ubc13 as 
partner. hMMS2 and hUbc13 interact through a narrow interface approximately 30 Å long and 
10 Å wide. The interior formed by hydrophobic residues of Ubc13 include Phe57, Tyr34 and 
Leu83 which are not conserved in other E2s. Phe57 and Leu83 contribute number of van der 
Waal contacts which stabilize the complex. Hydrophobic residues from hMms2, Phe13 and Val7 
form the hydrophobic interior of it. Charged residues, Asp38 and Glu39, in the extended L1 loop 
of hMms2 provide hydrogen bonds that other E2s do not possess. These two differences 
explain why other E2s have not been reported to recognize hUbc13. (Moraes et al. 2001) 
 
3.4 Lys63 linked polyubiquitination: 
 
Lys63 linked Poly-Ub chains have been found to participate in DNA Repair (Brusky et al. 2000), 
the NF-kB signaling pathway (Broomfield et al. 2001; Finley 2001), activation of stress-activated 
protein kinases (SAPKs) (Shi and Kehrl 2003), and ribosome function (Spence et al. 2000). 
 
Lys63 linked Poly-Ub chains synthesis requires the presence of heterodimer formed by E2 
enzyme (hUbc13) and its variant (UEV). UEVs are proteins that are structurally and sequentially 
similar to Ubcs but lack the active site cysteine residue hence catalytically inactive. Uev1a, a 
UEV apart from Mms2 differs from latter by an N-terminal extension (Anderson et al. 2005; 
Broomfield et al. 1998; Brusky et al. 2000). Despite having sequence similarity of ~90% in core 
domain, two UEVs function differently (Anderson et al. 2005). Ubc13- Mms2 heterodimer was 
found to be involved in error-free Post-replicative Repair Pathway (PRR) in Yeast (Broomfield et 
al. 1998). Mms2 is required in DNA damage response whereas Uev1a is involved in NF-kB 
signaling pathway. Hence, UEV members differentially regulate function of E2 (Ubc13) 
(Anderson et al. 2005). 
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3.5 Uev1a: Structure and Function 
 
Solution structure of Uev1a shows the presence of core UEV domain and an unstructured 35 
residue long N-Terminus which are likely to be solvent accessible. The core UEV fold is 
composed of N-terminal  helix, 1 (36-49), followed by a four-strand, antiparallel  sheet (1, 
56-59; 2, 69-77; 3, 86-94; and 4, 104-107) and two C-terminal  helices (2, 140-152; and 
 
3, 154-157), 2 forms extensive contacts with one face of the  sheet (Figure 5). Chemical 
shift mapping of Uev1a on titration with Ubc13 showed interacting residues around 1 helix and 
neighboring loop or strands. Eight residues of Uev1a are involved in interaction with hUbc13 
(Hau et al. 2006). Uev1a interacts with various E3s downstream signaling pathway to achieve 
its function. Two such E3 include TRAF6 (Tumor Necrosis Factor (TNF) Receptor Associated 
Factors) and CHIP (C-Terminal peptide from Human Hsp90). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Ribbon representation of 33-170 residues of hUev1a. (Adapted from Hau et al. 2006). 
 
TRAF6 is a RING-type E3 that facilitates Lys63 linked polyubiquitination.TRAF6 
polyubiquitinates itself and downstream signaling proteins on specific ligand stimulation. 
Polyubiquitination of target proteins requires E2 (Ubc13) and its variant (Uev1a) (Pickart and 
Eddins 2004). The Lys63 linked Poly-Ub chains acts as anchors for recruiting IKK which 
phosphorylates IKB leading to its degradation and frees NF-KB for transcription (Chen et 
al.2009). 
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Figure 6: A dimeric TRAF6/Ubc13/Uev1A complex. (Adapted from Yin et al. 2009) 
 
CHIP is a U box E3 Ubiquitin ligase that binds to Hsp proteins and ubiquitylates it leading to 
degradation of chaperone bound client proteins. CHIP associates with Ubc13-Uev1a to form 
Lys63 linked Poly-Ub chains for performing its function. Crystal structure of heterotrimer 
complex of Ubc13-Uev1a-CHIP U box domain is available. The protomers in the homodimeric 
CHIP protein are asymmetric making only one binding site available for Ubc for the synthesis of 
Poly-Ub chains (Zhang et al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Homodimer of Ubc13-Uev1a-CHIP. (Adapted from Zhang et al. 2009) 
 
 
NMR-based chemical shift mapping experiments of Ubc13 or Ub showed that the unstructured 
N-terminus tail does not interact with Ub or Ubc13. Since Uev1a interacts with E3 for performing 
its function, it is likely that it interacts with them (Hau et al.2006). N-terminal 35 residues are not 
observed in the crystal structure of Ubc13-Uev1a-CHIP U box heterotrimeric complex. Also, 
there is a lack of structural data on TRAF6 interaction with Ubc13-Uev1a. Interactions involving 
N-Terminus of Uev1a with respective E3s is therefore not completely understood structurally. 
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4. OBJECTIVES: 
 
Part I 
 
1) To generate a mutant Mms2 protein: T5K, express in bacteria and purify it. 
 
Part II 
 
1) To obtain sequences similar to Uev1a for template selection.  
 
2) To Model the unstructured N-terminal 35 residues of Uev1a based on templates, to study the 
possible secondary structure it can adopt in heterotrimer complex.  
 
3) Dock the modeled peptide to Uev1a, Ubc13-Uev1a heterodimer and Ubc13-Uev1a-CHIP 
heterotrimer to study its interactions.  
 
5. RATIONALE 
 
Part I 
 
Ubc13, a ubiquitin-conjugating enzyme requires co-factor to perform its function. Ubiquitin-
conjugating enzyme Variants (UEVs) are the proteins that act as co-factors. Mms2, a Uev 
protein conjugates with Ubc13 to synthesize Lys-63 linked poly-ubiquitin chains for signaling in 
DNA repair (Hoffman et al. 1999; McKenna et al. 2001). It has also been demonstrated that 
another UEV, Uev1A conjugates with Ubc13 to synthesize Lys-63 linked poly-ubiquitin chains 
that is involved in NF-kB activation. Hence, UEV family proteins in higher eukaryotes have 
evolved to differentially regulate E2 function (Anderson et al. 2005). UEVs, Mms2 and Uev1A 
share more than 90% sequence similarity. The varying amino-acids in two UEVs could regulate 
the activity of Ubc13 differentially and swapping these residues would aid in understanding the 
regulation of two distinct biological pathways. 
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Part II 
 
Ubc13 is an E2 enzyme that requires presence of Uev protein to synthesize Lys63 linked Poly-
Ub chains (Hoffman and Pickart 1999). TRAF6 is a RING domain possessing E3 Ligase that 
requires the presence of Ubc13-Uev1a for synthesis of Poly-Ub chains that leads to activation of 
IKK followed by NF-KB activation (Deng et al. 2000). CHIP is a U box E3 ligase that acts as a 
functional partner for the Ubc13-Uev1a heterodimer for chaperone bound client protein 
degradation. Structure of Ubc13-Uev1a-CHIP has been crystallized with only the U box domain 
of CHIP (Zhang et al. 2005). There is no structural information regarding interaction of CHIP and 
TRAF6 with the N-terminus of Uev1a. Hence, studying the interaction would aid in 
understanding the role of N-terminus in deciding the respective E3 ligases. 
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6. METHODS: 
 
Part I 
 
6.1 Site Directed Mutagenesis: 
 
To generate mutant MMS2 gene, overlap PCR was performed. This was done by performing 
two rounds of PCR with insert specific primers and with primers introducing mutations on MMS2 
gene. In first round of PCR, the set of primers used for two independent reactions were: 
 
1) Forward primer of Insert (MMS2) and antisense primer for mutation and  
 
2) Reverse primer of Insert and sense primer for mutation, respectively. 
Forward primer for MMS2:  
 
5` CGT GGA TCC ATG GCG GTC TCC ACA GGA G 3` (BamHI site 
incorporated) Reverse primer for MMS2:  
 
5` CCG CTC GAG TTA ATT GTT GTA TGT TTG TCC TTC TG 3` (XhoI site incorporated)  
 
For second round of PCR, insert specific primers were used to amplify the products of first PCR. 
For T5K, only one round of PCR was performed with Mutant forward primer and reverse primer 
for insert as mutation to be introduced was towards the start of insert.  
 
Mutant forward primer for T5K:  
 
5` CGT GGA TCC ATG GCG GTT TCG AAA GGA GTT AAA G 3`  
 
Mutant Reverse Primer for T5K:  
 
5` CCG CTC GAG TTA ATT GTT GTA TGT TTG TCC TTC TG 3`  
 
PCR Conditions used for first cycle of denaturation was 95oC for 3 mins. For Step 2, 
denaturation (95oC, 15 secs) was followed by Annealing (50oC, 15 secs) and extension (68oC, 
45 secs) for 25 cycles. Final Extension for 5 mins was done at 68oC followed by hold at 4oC.  
Ligation reactions were performed to clone mutant PCR product to pRSETA vector after 
restriction digestion with BamHI and XhoI respectively. Screening of mutant was performed by 
restriction digestion with BstBI which was the restriction site gained on introducing mutation.  
 
Transformation into DH5-α cells was followed by screening to obtain positive clones with mutant 
gene.  
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6.2 Protein Expression and Purification: 
 
BL21 (DE3) pLysS competent cells transformed with recombinant plasmid harboring T5K 
mutant were allowed to grow till 0.6 O.D measured at 600nm, 37oC and induced with 1mM of 
IPTG. Induced cells were pelleted after four hours of incubation at 37oC. Cells were suspended 
in ice-cold lysis buffer (50mM Tris-Cl pH 8, 150mM NaCl, 20mM Imidazole, 1mM BME, 0.5% 
Triton X-100, 1mM PMSF), sonicated and centrifuged to obtain supernatant containing the 
protein of interest. The cell lysate was then added to Ni-NTA column equilibriated with ice-cold 
buffer (50mM Tris-Cl pH 8, 150mM NaCl, 20mM Imidazole, 1mM BME, 0.5% Triton X-100). 
After nutation for one hour, at 4oC, flow through was collected and column was washed with ice-
cold wash buffer (50mM Tris-Cl pH 8, 150mM NaCl, 20mM Imidazole) thrice the volume of 
column. Elutions were then collected by adding ice-cold elution buffer (50mM Tris-Cl pH 8, 
150mM NaCl, 400mM Imidazole). Elution with maximum concentration of protein was dialyzed 
in ice-cold buffer containing 50mM Tris-Cl pH 8 and150mM NaCl for four hours on ice. Dialyzed 
protein was stored in equal volume of glycerol at -20 oC. 
 
Part II 
 
Solution structure of hUev1a (2HLW) and crystal structure of Ubc13-Uev1a-CHIP (2C2V) was 
obtained from PDB. Structure was visualized and analyzed using PyMol. FASTA format of 
hUev1a sequence was obtained from NCBI PubMed (NCBI Reference Sequence: 
NP_068823.2). BLAST was performed for the N-Terminal 35 residues of Uev1a to obtain 
templates for homology modeling. Protein blast was chosen and FASTA sequence of 35 
residues was entered. Protein Data Bank protein (PDB) was chosen as database to obtain 
sequences that possess structural information in PDB. Sequences of hits chosen as templates 
were obtained from NCBI PubMed and structure from PDB. Multiple Sequence Alignment for 
Uev1a and template strands was performed in Clustal-W. 
 
Discovery Studio 4.0 Client was used to build model for 35 residues of hUev1a. FASTA 
sequences of 35 residues of hUev1a and templates (Single Stranded Binding Proteins) was 
obtained and accessed in Discovery Studio. 
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6.3 Modeling 35 residues: 
 
Open the FASTA sequence of hUev1a with 35 residues in Discovery Studio. In Macromolecules 
 
Tab, click on Align Sequences and Structures followed by Align Sequence profile. (Prior to the 
step, align template sequences by opening the sequences in a single FASTA file and clicking on 
Align Sequences). In the window that appears on clicking Align Sequence Profile, choose the 
pre-aligned template sequences as Input Sequence Alignment and choose 35 residues of 
hUev1a N-Terminus as Input Sequence Set and click on Run. 
 
Open the crystal structure of the templates in a single file (Copy the structure and paste). Click 
on Create Homology Models in Macromolecules tab followed by Align Sequence to Templates. 
Choose the newly aligned file of template and model sequence as Input Model Sequence and 
template structures (in the same molecule window) as Input Template Structure and click on 
 
Run. 
 
Click on Build Homology Models and choose final alignment sequence as Input Sequence 
Alignment, final structure output as Input Template Structure and 35 residue long hUev1a as 
Input Model Sequence. Click on Run. 
 
20 Models will be generated on Job completion. To assess the validity of 3D structure, Click on 
 
Verify Protein (Profiles-3D) under Create Homology Models. Choose the model generated file 
as Input Protein Molecules and click on Run. 
 
6.4 Cleaning the crystal structure of protein prior docking: 
 
Open the crystal structure of Ubc13-Uev1a-CHIP in Discovery Studio and change the display 
style. Change the protein representation to flat ribbon and color by Secondary type. 
 
Click on Structure in the toolbar and Crystal Cell in the dropdown and click on Remove Cell. 
 
Click on Macromolecules Tab, Protein Report and if any ligands or water molecules found, 
delete them. 
 
In the same tab, click on Prepare Protein followed by Clean Protein and Show Clean Report. 
Alternate confirmations of proteins will be reported. 
 
This is followed by Prepare Protein Step. In the window that appears, change the pH and Ionic 
strength according to conditions mentioned in published papers. Click on Run. 
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On job completion, a file opens as protein name_prep and reports about missing residues etc. 
Validate the structure on clicking X-ray (or Macromolecules) Tab and click on Validate Protein 
Structure followed by Perform Validations, Check Structure. 
 
This gives the summary of residues residing in the disallowed regions and main chain and side 
chain violations. 
 
In main chain confirmation violations, if any residues lie in the Disallowed region, Click on 
Protocols, followed by Discover Studio > Macromolecules > Refinement > Loop Refinement > 
Modeller > Select residues in the disallowed region present in the loops > Run. 
 
Modeller creates models and the one with least DOPE Score will be displayed on top of the 
results. This model can be validated again to check if the violations have reduced, if not perform 
the above process again to reduce the number of residues lying in the disallowed region. 
 
For residues with side chain violations, Protocols, followed by Discovery studio > 
Macromolecules > Refinement > loop refinement > side chain refinement > Select all the 
residues listed in the side chain incorrect confirmation report > Run. 
 
Model with least DOPE Score and minimized violations can then be saved as clean protein for 
further docking study. 
 
6.5 Docking the modeled peptide on to refined protein complex: 
 
Model with high Verify score has to be docked with 1) Uev1a alone, 2) Ubc13-Uev1a and 3) 
Ubc13-Uev1a-CHIP heterotrimer. To dock with Uev1a alone, open the heterotrimer file (2C2V) 
select chain H and chain T and press delete. Refine the protein as per the steps mentioned 
above and choose the model with least energy. For heterodimer complex, choose chain T and 
delete and refine the protein and choose the model with lowest energy. For heterotrimer 
complex, refine the complex 2C2V which has only three chains (I, H and T). 
 
Open the refined Model structure and crystal structure of heterotrimer complex to be docked in 
Discovery Studio. Click on Dock and Analyze Protein Complexes followed by Dock Proteins 
(ZDOCK). Select least energy model of receptor protein as Input Receptor Protein and the best 
model obtained as Input Ligand Protein. Choose Angular Step Size as 6. Expand Filter Poses 
and choose Val36 (Click on the residue and define group in prior) as Receptor Binding Site 
Residues and click on Run. 
 
On Job completion, click on View Results and analyze Docked Poses by browsing through 
 
Poses in a Cluster. 
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7. RESULTS AND DISCUSSIONS: 
 
Part I 
 
7.1 Screening of pRA19, MMS2T5K: 
 
DH5-α cells transformed with Ligated vector and Insert (T5K MMS2) were screened for 
presence of positive clones which possess recombinant plasmid. Miniprep for Plasmid Isolation 
was performed for 10 colonies and DNA isolated was loaded on 0.6% agarose gel. Mobility shift 
was detected in DNA of three colonies. Figure 8 shows the observed mobility shift for colony-4, 
colony-7 and colony-8 (C4, C7 and C8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Screening of Colonies for positive clone. Isolated DNA was run on 0.6% agarose 
at 50V. Control Vector pRSETA was loaded on L1 and plasmid isolated from colony 1 to colony 
10 by MiniPrep was loaded on L2 to L11, denoted by C1 to C10 in the figure. Band 
corresponding to Vector was observed in colonies except C4, C7 and C8 where mobility shift 
was observed. 
 
7.2 Insert Release of pRA19 
 
Confirmation of Insert in colonies showing mobility shift was done by digesting the DNA with 
restriction enzymes used to clone the insert into pRSETA vector. Restriction enzymes BamHI 
and XhoI were used to check the release of insert from C4, C7 and C8 DNA. After Incubation of 
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DNA with compatible buffer and respective enzymes for four hours, DNA was run on 0.6% 
agarose gel. Insert release was observed (Figure 9) and band corresponding to approximately 
430bp was observed on gel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Insert Release for C4, C7 and C8 DNA with BamHI and XhoI. L1, L4 and L5 were 
loaded with Uncut DNA of C4, C7 and C8 respectively. Digested DNA of C4, C7 and C8 was 
loaded on L2, L5 and L7 respectively. 1kb DNA ladder was loaded on L3. Band size of ladder 
is indicated to the left of figure in kbs. Linearized vector of approximately 3kb was observed 
apart from Insert of 438bp. 
 
7.3 Mutant screening of pRA19 
 
Insert release was confirmed by digesting DNA with BamHI and XhoI. To confirm the generation 
of mutant site, mutation screening was performed. BstBI is a restriction site gained by pRA19 on 
introducing the mutation. Digestion was performed with BstBI, restriction site already present in 
vector. Hence, wild type MMS2 would show only single band in comparison to mutant MMS2 
having two BstBI sites. 
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Figure 10: Mutant Screening of pRA19 by BstBI digestion. L1 and L3 were loaded with 
uncut pRA18 and pRA19 DNA respectively. L2 and L4 were loaded with BstBI digested DNA 
of pRA18 and pRA19 respectively. 1kb DNA ladder was loaded on L5. Band size of ladder is 
indicated to the left of figure in kbs. pRA18 carrying wild-type MMS2 showed only single 
linearized band whereas a band of 450bp was observed in pRA19 cut DNA showing presence 
of two BstBI sites in pRA19 mutant. 
 
7.4 Induction with IPTG 
 
Transformation of mutant plasmid to BL21 (DE3) pLysS was performed after confirmation of 
mutant site. Cells were allowed to grow overnight at 37
o
C and this served as pre-inoculum for 
performing induction of 125ml culture. Uninduced and Induced cells corresponding to 0.15 O.D 
was loaded on 12.5% SDS PAGE to check the presence of induced band. Figure 11 shows the 
presence of Induced band between 25 and 20kDa. 
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Figure 11: Induction check for pRA19. Cells corresponding to 0.15 O.D was loaded on 12.5% 
SDS PAGE to check for induced band of desired molecular weight. L1 was loaded with 
uninduced sample, L2 was loaded with induced sample and L3 was loaded with protein marker 
molecular weight indications of which are given towards right (in kDa). Induced band of 
approximately 23 kDa was observed in the gel image. 
 
7.5 Protein Purification 
 
Induced cells were pelleted and suspended in lysis buffer, sonicated and centrifuged to obtain 
cell pellet and lysate. Lysate is then added to Ni-NTA column equilibriated with buffer. After 
nutation for an hour in 4
o
c, flow through was collected and column was washed with wash buffer 
thrice the volume of column. Five elutions were then collected after adding elution buffer 
containing 400mM imidazole. Figure 12 shows protein eluted run on 12.5% SDS PAGE along 
with cell pellet, Lysate, flow through, wash and protein ladder. Desired protein of 23kDa was 
collected in third elution in higher amounts. 
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Figure 12: Purified protein run on 10% SDS PAGE. His-tagged MMS2 was purified by Ni-
NTA affinity purification method. Cell pellet resuspended in 1X-Tris Glycine was loaded on L1, 
Lysate containing protein was loaded on L2, Flow through collected after nutation was 
collected in L3 followed by wash on L4. Protein ladder was loaded on L5 (molecular weight 
indications of which are shown to the right of the figure) followed by five elutions of protein. 
Elution 3 showed dense band of protein indicating highest amount eluted. 
 
7.6 Screening of Wild-type MMS2, pRA18 
 
Screening for wild-type MMS2 is performed after transforming the ligated product of Digested 
pRSETA vector and digested PCR amplified MMS2 insert into DH5-α. Only one round of PCR is 
performed for Wild-type in comparison to mutant. Plasmid isolated was run on agarose gel to 
screen colonies transformed with recombinant plasmid. Figure 13 shows the mobility shift 
observed in DNA in comparison to control pRSETA vector. 
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Figure 13: Screening of Wild-type MMS2. Plasmid isolated from colonies was loaded on 
agarose gel. Control Vector loaded on L1 is pRSETA followed by DNA isolated from Colony 
and Colony 2 in L2 and L3 respectively. Mobility shift was observed in colonies indicating 
presence of Insert. 
 
7.7 Insert Release for Wild-type MMS2. 
 
To confirm the presence of insert, DNA was digested with restriction enzymes used to clone the 
insert. BamHI and XhoI were used to check the release of insert of 438bp. Insert release was 
observed in DNA isolated confirming presence of wild-type MMS2 in recombinant plasmid 
(Figure 14). 
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Figure 14: Insert release of pRA18 with BamHI and XhoI. L1 was loaded with Uncut DNA 
which showed mobility shift. Digested DNA was loaded on L2. 1kb DNA ladder was loaded on 
L3. Band size of ladder is indicated to the left of figure in kbs. Linearized vector of 
approximately 3kb was observed apart from Insert of 438bp. 
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Part II 
 
7.8 PyMol Analysis: 
 
Solution structure obtained from PDB was analyzed using PyMol and the length of 35 residues 
was measured. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Solution structure of hUev1a as visualized through PyMol. 
 
The 35 residues marked in red (Figure 15) forms an unstructured loop and the maximum 
distance measured from the secondary structure was 47.1 Angstrom. 
 
Crystal Structure of Ubc13-Uev1a-CHIP was analyzed considering only one unit of the 
heterotrimer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: One Subunit of Ubc13-Uev1a-CHIP heterotrimer complex. Structure in red is the U Box 
domain of CHIP, Blue is Ubc13 and Yellow is Uev1a. 
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From the heterotrimer complex, it can be inferred that the maximum distance a structure 
(extending from Val-36) can adopt to occupy the cleft formed by the three proteins is 28 
Angstrom. 
 
Hence, there can be possibility of N-Terminal 35 residues forming a reordered secondary 
structure when the protein interacts with Ubc13 and CHIP. The reordered secondary structure 
could either interact with Ubc13 or E3 (CHIP) or fold back to its own structure. 
 
A Model of 35 residues generated could hence be docked to the heterotrimer complex to 
understand the possible interactions with proteins involved. 
 
7.9 BLAST and MSA Results: 
 
BLAST results of 35 residue long N-Terminus showed hits as shown in the Figure 17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: BLAST results of sequences showing similarity to 35 residues of Uev1a N-Terminus 
 
Single Stranded Binding Proteins (3TQY, 3PGZ and 1SRU) showed similarity of ~60% 
similarity. PDB structure of the three proteins showed Helix-loop-extended beta sheet as three 
proteins possess structural similarity. 4QEA is a stationary phase survival protein (sure) which 
possesses more that 60% similarity with the sequence of interest. Structure of 4QEA included 
two beta strands separated by a loop. Sequences of SSBs and sure were obtained from 
PubMed and MSA was performed in Clustal W2. When 4QEA was excluded there was an 
increase in the number of similar and identical residues. Hence, MSA was performed again with 
Uev1a 35 residues and 3 SSB sequences that shared more than 60% similarity in BLAST. 
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Figure 18: MSA results of sequences showing similarity to 35 residues of Uev1a N-Terminus. 
 
Results showed 18 identical residues and 9 similar residues to 2HLW (Uev1a sequence). Hence 
the 3 SSB structure was chosen as template for proceeding with homology modeling. 
 
7.10 Homology Modeling Results: 
 
Sequence alignment of SSBs and Uev1a was performed in Discovery Studio prior to homology 
modeling. Figure 19 shows the alignment results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Sequence alignment of SSBs and Uev1a performed in Discovery Studio. 
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Figure 20: Structure of Three SSBs in a single molecule window 
 
20 Models were then obtained after steps elaborated in Methods. Validation was performed and 
Verify score was obtained for 20 models obtained (Figure 21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Structure of 20 models generated. Model 10 is shown in the window along with alignment. 
 
Model 10 was chosen as it had the Highest Verify Score of 3.62 and Total PDF Energy of 
442.68 and DOPE Score of -1067.73 (Figure 22). Model 10 possessed residues till Lys28. 
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Figure 22: Verify Score of 20 models generated. Model 10 is shown in the window along with alignment. 
 
7.11 Docking Results: 
 
On Docking, 2000 poses were obtained for each complex. 6000 poses were analyzed and the 
distance between Val36 of Uev1a and Lys28 of modeled peptide was measured. The least 
possible distance between two residues is 10.8 Angstrom as the seven intermediate residues 
could form a helix of two turns (One turn length: 5.4 Angstrom). The Maximum distance of 28 
Angstrom is possible if they form an extended structure like in solution structure available. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Model 10 docked with Uev1a alone. Pose shows the distance between Val36 of receptor and 
 
Lys28 of Model. 
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Figure 24: Model 10 docked with Ubc13-Uev1a alone. Pose shows the distance between Val36 
of receptor and Lys28 of Model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Model 10 docked with Ubc13-Uev1a alone. Pose shows the distance between Val36 
of receptor and Lys28 of Model. 
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Model 10 Docked to Uev1a alone showed 787 permissible poses out of 2000. 
 
Model 10 Docked to Ubc13-Uev1a showed 609 permissible poses out of 2000. 
 
Model 10 Docked to Ubc13-Uev1a-CHIP Heterotrimer showed 572 permissible poses out of 
2000 out of which 147 poses were not found to interact with CHIP. 
 
Hence, 21.2% of poses analyzed were found to interact with CHIP compared to 39% that was 
observed when docked to Uev1a alone which reduced to 30.5% in Ubc13-Uev1a Heterotrimer 
complex. Hence, there are chances of N-Terminus of Uev1a interacting with E3 Ligase which 
may determine the final biological function. 
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